Published in Medicine (Baltimore) on March 01, 2000
New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol (2010) 1.36
The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol (2003) 1.06
Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am J Kidney Dis (2008) 0.88
Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne) (2014) 0.77
Hemolytic uremic syndrome after renal transplantation. Hippokratia (2006) 0.76
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant (2010) 5.40
A common core RNP structure shared between the small nucleoar box C/D RNPs and the spliceosomal U4 snRNP. Cell (2000) 4.33
Inhibition of membrane-bound adenosine triphosphatase and of cation transport in Streptococcus faecalis by N,N'-dicyclohexylcarbodiimide. J Biol Chem (1969) 3.58
Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet (1996) 3.48
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet (1992) 3.30
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med (1997) 3.01
Selenoprotein synthesis: an expansion of the genetic code. Trends Biochem Sci (1991) 2.99
Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin Pharmacol Ther (2010) 2.94
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81
Pefloxacin as first-line treatment in nephrotic syndrome. Lancet (1992) 2.58
The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) (1979) 2.58
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet (2004) 2.55
Reliability of goniometric measurements. Phys Ther (1978) 2.52
Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med (1983) 2.50
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem (1998) 2.37
Coding from a distance: dissection of the mRNA determinants required for the incorporation of selenocysteine into protein. EMBO J (1992) 2.29
Solubilization of bacterial membrane proteins using alkyl glucosides and dioctanoyl phosphatidylcholine. Biochim Biophys Acta (1975) 2.29
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Creatine kinase-BB: a marker of liver sinusoidal damage in ischemia-reperfusion. Hepatology (1993) 2.23
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med (1994) 2.14
Anti-glomerular-basement-membrane disease after lithotripsy. Lancet (1990) 2.11
Clinical operational tolerance after kidney transplantation. Am J Transplant (2006) 2.09
Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res (1997) 2.09
Quantification of articular cartilage in the knee with pulsed saturation transfer subtraction and fat-suppressed MR imaging: optimization and validation. Radiology (1994) 2.05
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients. Clin Pharmacol Ther (2009) 2.04
Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation (2001) 2.03
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant (2010) 2.03
Vir proteins stabilize VirB5 and mediate its association with the T pilus of Agrobacterium tumefaciens. J Bacteriol (1999) 1.93
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93
Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant (2010) 1.92
Osteoarthritis of the knee: comparison of radiography, CT, and MR imaging to assess extent and severity. AJR Am J Roentgenol (1991) 1.91
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant (2012) 1.90
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90
Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89
Percutaneous balloon valvotomy of congenital pulmonary stenosis using oversized balloons. J Am Coll Cardiol (1986) 1.89
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med (2001) 1.88
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant (2010) 1.86
Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation (2001) 1.85
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83
False-positive HIV antigens related to emergence of a 25-30 kD protein detected in organ recipients. AIDS (1992) 1.82
Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol (2000) 1.80
Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant (2011) 1.77
De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant (2012) 1.74
Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: minimal estimates of production and turnover rates of mature lymphocytes. Eur J Immunol (1990) 1.74
Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med (2000) 1.74
Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (1981) 1.71
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant (2009) 1.67
Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature. Clin Nephrol (1992) 1.66
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant (2009) 1.65
Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol (2001) 1.64
Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore) (2000) 1.61
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant (2012) 1.60
Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology (1992) 1.60
Results of the arterial switch operation for transposition of the great arteries with ventricular septal defect. Surgical considerations and midterm follow-up data. Circulation (1989) 1.60
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer (1995) 1.59
Carbodiimide-resistant membrane adenosine triphosphatase in mutants of Streptococcus faecalis. I. Studies of the mechanism of resistance. J Biol Chem (1972) 1.58
Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell (2001) 1.57
Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int (1989) 1.56
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation. Am J Transplant (2009) 1.55
Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study. Int J Radiat Oncol Biol Phys (1996) 1.55
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology (1995) 1.54
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res (1998) 1.53
In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation (1990) 1.53
Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant (2009) 1.52
Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant (2001) 1.50
Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Nephrol Dial Transplant (1995) 1.49
Nonprocurement of transplantable organs in a tertiary care hospital: a focus on sociological causes. Transplantation (1996) 1.49
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant (2007) 1.49
Dialysis arthropathy: outcome after renal transplantation. Am J Med (1995) 1.48
Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med (1993) 1.48
Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant (2004) 1.48
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. Am J Transplant (2013) 1.48
Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med (1998) 1.47
A new method for delivering radioactive cytotoxic agents in solid cancers. Int J Radiat Oncol Biol Phys (1994) 1.47
Toxoplasma colitis in the acquired immunodeficiency syndrome. Am J Gastroenterol (1992) 1.46
Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int (1996) 1.45
Anomalous origin of left coronary artery from pulmonary artery. Ligation versus establishment of a two coronary artery system. J Thorac Cardiovasc Surg (1987) 1.45
Chronic hepatitis in kidney allograft recipients. Lancet (1990) 1.45